— Know what they know.
Not Investment Advice
Also trades as: GILD.SW (SIX) · $vol 18M · GILD.TO (TSX) · $vol 0M · GIS.DE (XETRA) · $vol 0M

GILD Short Interest

Gilead Sciences, Inc.
1W: +3.7% 1M: +5.1% 3M: +18.1% YTD: +30.5% 1Y: +32.3% 3Y: +118.5% 5Y: +182.7%
$159.08
+0.39 (+0.25%)
After Hours: $158.15 (-0.93, -0.58%)
Weekly Expected Move ±4.0%
$144 $150 $156 $162 $169
NASDAQ · Healthcare · Drug Manufacturers - General · Tech Score Strong Buy · Power 74 · $196.8B mcap · 1.24B float · 0.530% daily turnover · Short 48% of daily vol
Credit Risk of going bust: lower than 84% of companies Debt: 11.8% of company value Bonds: $407.1M held by 325 funds, 58 bp over Treasuries → details ▾
Of US companies ranked in the safest four tenths, about 1 in 3,500 filed for bankruptcy within a year (2020-2025).
If the stock fell to about $1.38 (down 99.1%), Gilead Sciences, Inc. would be worth roughly what it owes.
Total debt $26.25B against a stock market value of $196.77B.
Distance to default 10.79 (Merton model): prices to 2026-10-26, balance sheet 2026-06-30, debt counted $14.33B (short-term plus half of long-term), stock volatility 26.8%; Altman Z 3.79. A ranking and a back-test, not a forecast.
Bond figures are fund-reported marks (SEC N-PORT) as of Jul 2026. How these are computed.

Short Volume Summary

2026-10-26
61.1%
Short Ratio
of total volume
45.9%
20-Day Avg
42.6%
50-Day Avg
▲ Rising
5-Day Trend
1.5M
Short Volume
2.5M
Total Volume

Daily Short Volume Ratio

Short Volume vs Total Volume

Exchange Breakdown

2026-10-26
ExchangeShort VolumeTotal VolumeShort %
NASDAQ 1,422,640 2,330,418 61.0%
NYSE 85,594 138,223 61.9%
BATS 3,327 5,511 60.4%

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms